Dr. Hickstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10/Crc, Room 3-3142
Bethesda, MD 20892Phone+1 301-594-1718Fax+1 301-402-5054
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1983 - 1987
University of MichiganResidency, Internal Medicine, 1978 - 1981
University of Nebraska College of MedicineClass of 1978
Certifications & Licensure
WA State Medical License 1982 - 2025
MI State Medical License 1979 - 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
Clinical Trials
- Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC Start of enrollment: 2009 May 07
- Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency Start of enrollment: 2010 Oct 05
- A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2010 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsHematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.Hasan Hashem, Giorgia Bucciol, Seza Ozen, Sule Unal, İkbal Ok Bozkaya
Journal of Clinical Immunology. 2021-07-29 - 39 citationsAdenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.Amy P. Hsu, Robert R. West, Katherine R. Calvo, Jennifer Cuellar-Rodriguez, Mark Parta
The Journal of Allergy and Clinical Immunology. 2016-08-01 - 454 citationsDonor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose
Blood. 2013-12-12
Journal Articles
- Original Article Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencyDennis D Hickstein, Ashish Kumar, Suhag H Parikh, Raif S Geha, ScienceDirect
Press Mentions
- CRISPR-Cas9 Fusion to Dominant-Negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target SitesJune 28th, 2020
Gene Defect Predisposes People to LeukemiaSeptember 5th, 2011
Grant Support
- Allotransplant For DOCK8 DeficiencyNational Cancer Institute2011
- Zebrafish Models Of CancerNational Cancer Institute2010–2011
- Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSNational Cancer Institute2010–2011
- Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyNational Cancer Institute2010–2011
- Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyDivision Of Clinical Sciences - Nci2009
- Zebrafish Models Of CancerDivision Of Basic Sciences - Nci2009
- Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSDivision Of Basic Sciences - Nci2009
- Zebrafish Models Of CancerNational Cancer Institute2008
- Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSNational Cancer Institute2008
- Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyNational Cancer Institute2007–2008
- Zebrafish Models Of Human Leukemia And SarcomaNational Cancer Institute2007
- Zebrafish Models Of Human Leukemia And SarcomaDivision Of Basic Sciences - Nci2005–2006
- Hematopoietic Stem Cell Gene Therapy For Leukocyte AdhesDivision Of Clinical Sciences - Nci2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
